Medicure Inc.

Latest

Sep 17, 2019, 09:59 ET Medicure Announces Launch of New and Improved ReDS™ PRO

WINNIPEG, Sept. 17, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the launch of the ReDSTM PRO...


Aug 21, 2019, 17:00 ET Medicure Announces Settlement of Patent Infringement Action

WINNIPEG, Aug. 21, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announces that its subsidiary, Medicure International ...


Aug 08, 2019, 17:30 ET Medicure Reports Financial Results for Quarter Ended June 30, 2019

WINNIPEG, Aug. 8, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter ended June 30,...


Aug 02, 2019, 09:57 ET Medicure Q2 2019 Results and Conference Call Dates

WINNIPEG, Aug. 2, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, will release financial results for the quarter ended June 30, 2019 on...


Jun 26, 2019, 18:00 ET Medicure Announces Results of 2019 Annual Meeting of Shareholders

WINNIPEG, June 26, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJD.PK), a pharmaceutical company, today announced the results of its annual meeting of shareholders which ...


Jun 10, 2019, 17:30 ET Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer

WINNIPEG, June 10, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH, OTC: MCUJD.PK), a pharmaceutical company, today announced that Dr. Neil Owens has been appointed President and...


May 30, 2019, 09:30 ET Medicure Announces Renewal of its Normal Course Issuer Bid

WINNIPEG, May 30, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is pleased to announce that the TSX Venture Exchange ("TSXV") has accepted...


May 27, 2019, 17:30 ET Medicure Reports Financial Results for Quarter Ended March 31, 2019

WINNIPEG, May 27, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter ended March 31,...


May 22, 2019, 18:00 ET Medicure Q1 2019 Results and Conference Call Dates

WINNIPEG, May 22, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, will release financial results for the quarter ended March 31, 2019 on...


May 15, 2019, 17:30 ET Medicure Appoints Ms. Manon Harvey to its Board of Directors

WINNIPEG, May 15, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH, OTC: MCUJD.PK), a pharmaceutical company, today announced the appointment of Manon Harvey CPA, CA, to the Board...


Apr 29, 2019, 17:30 ET Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018

WINNIPEG, April 29, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter and year ended ...


Apr 24, 2019, 18:44 ET Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019

WINNIPEG, April 24, 2019 /CNW/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, will release financial results for the year ended December 31, 2018 after markets close on ...


Feb 13, 2019, 17:00 ET Medicure Provides Update on Release of Holdback Funds from Apicore Sale

WINNIPEG, Feb. 13, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announced that it has received notice from the...


Jan 28, 2019, 17:00 ET Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States

INVESTS US$10.0 MILLION IN SENSIBLE MEDICAL WINNIPEG, Jan. 28, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to...


Nov 20, 2018, 17:00 ET Medicure reports financial results for quarter ended September 30, 2018

WINNIPEG, Nov. 20, 2018 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today reported its results from operations for the quarter...


Nov 16, 2018, 17:40 ET Medicure Files Patent Infringement Action

WINNIPEG, Nov. 16, 2018 /CNW/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announces that its subsidiary, Medicure International Inc., has filed...


Nov 14, 2018, 15:50 ET Medicure Q3 2018 Results and Conference Call Dates

WINNIPEG, Nov. 14, 2018 /CNW/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended September 30, 2018 on...


Aug 15, 2018, 17:30 ET Medicure Reports Financial Results for Quarter Ended June 30, 2018

WINNIPEG, Aug. 15, 2018 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today reported its results from operations for the quarter...


Aug 13, 2018, 11:30 ET Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

WINNIPEG, Aug. 13, 2018 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce that the United States Food and Drug ...


Aug 08, 2018, 17:00 ET Medicure Q2 2018 Results and Conference Call Dates

WINNIPEG, Aug. 8, 2018 /CNW/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended June 30, 2018 on...


May 23, 2018, 17:30 ET Medicure Reports Financial Results for Quarter Ended March 31, 2018

WINNIPEG, May 23, 2018 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today reported its results from operations for the quarter...


May 17, 2018, 18:00 ET Medicure Q1 2018 Results and Conference Call Dates

WINNIPEG, May 17, 2018 /CNW/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the first quarter ended March 31, 2018 on...


May 17, 2018, 17:00 ET Medicure Announces Normal Course Issuer Bid

WINNIPEG, May 17, 2018 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce that the TSX Venture Exchange...


May 01, 2018, 22:47 ET Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017

WINNIPEG, May 1, 2018 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today reported its results from operations for the quarter...


May 01, 2018, 07:00 ET Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S.

WINNIPEG, May 1, 2018 /CNW/ - Medicure (TSXV:MPH) today announced that pitavastatin magnesium (ZYPITAMAGTM) tablets are now available in retail pharmacies throughout the United States. ZYPITAMAGTM, a ...